human glucagon like peptide 1 Human Glucagon Like Peptide-1 - Glucagon-like peptide-1 structure Like Peptide 1 Understanding Human Glucagon-Like Peptide-1 (GLP-1)

Where is GLP-1 found Human glucagon-like peptide-1 (GLP-1) is a fascinating peptide hormone that plays a crucial role in regulating glucose metabolism and has garnered significant attention for its therapeutic potential. This article delves into the intricacies of this remarkable molecule, exploring its structure, function, and its implications in health and disease作者：TD Müller·2019·被引用次数：1917—Theglucagon-like peptide-1(GLP-1) is a multifaceted hormone with broad pharmacological potential. Among the numerous metabolic effects ofGLP-1are the ....

The Nature of Human Glucagon-Like Peptide-1

GLP-1 is a 30-amino acid peptide hormone derived from the post-translational processing of proglucagon. It is primarily synthesized and secreted by the L-cells of the intestinal epithelium in response to nutrient intake. While the full-length GLP-1 (1-37) exists, the biologically active form, particularly relevant for its incretin effects, is often considered to be GLP-1 (7-36) amide. This peptide is an insulinotropic hormone, meaning it stimulates insulin secretion from pancreatic beta cells. Furthermore, human GLP-1 exhibits a number of physiological properties that make it a subject of intensive investigation, particularly in the context of diabetes mellitus.

The structure of glucagon-like peptide-1 is a single polypeptide chain.The 9aaHumanGLP15-P controlpeptideis 100% conserved in mouse, rat, guinea pig, bovine and pig. No significant sequence homology is detected with other ... The molecular mass of Human Glucagon Like Peptide-1 is approximately 3297.7 Daltons for the 30-amino acid form.GLP-1is an insulinotropic hormone that has the ability to render pancreatic beta cells glucose-competent. It has been used in the therapy of type-2 diabetes. This human hormone is involved in energy homeostasis and is a key player in the meticulous control of human blood glucose levels. Its duration of action, however, is relatively short due to rapid degradation by the enzyme dipeptidyl peptidase-4 (DPP-4).

The Multifaceted Functions of Human GLP-1

The primary and most well-known function of GLP-1 is its role as an incretin hormone. Incretins are gut hormones released after a meal that enhance insulin secretion from the pancreas in a glucose-dependent manner.Glucagon-like peptide 1 (7-36) amide (human, rat) This means that GLP-1 stimulates insulin release when blood glucose levels are high, but has minimal effect when glucose levels are normal or low, thereby reducing the risk of hypoglycemia. This glucose-dependent insulin secretion is a key attribute that distinguishes human glucagon-like peptide-1 from other insulin secretagoguesGlucagon-like peptide 1 (GLP-1) - PMC.

Beyond its direct impact on insulin, GLP-1 has several other significant physiological effects:

* Glucagon Suppression: GLP-1 inhibits the secretion of glucagon from pancreatic alpha cells. Glucagon is a hormone that raises blood glucose levels by promoting the release of stored glucose from the liver.作者：JJ Holst·2007·被引用次数：4309—Glucagon-like peptide 1(GLP-1) is a 30-amino acid peptide hormone produced in the intestinal epithelial endocrine L-cells by differential ... By suppressing glucagon, GLP-1 further contributes to lowering blood glucose.

* Gastric Emptying: GLP-1 slows down the rate at which food leaves the stomachPeptides.Glucagon-Like Peptide 1,GLP-1(7-36), amide,human, mouse, rat, bovine, guinea pig. 1.00 0 %. Check your price. Cat.Number : AS-22462 .... This leads to a more gradual absorption of nutrients, including glucose, from the digestive tract, helping to prevent postprandial hyperglycemia.Human Glucagon Like Peptide-1 (GLP 1 Human)

* Appetite Regulation: GLP-1 acts on the brain to promote satiety and reduce appetite, which can contribute to weight management.

* Beta-Cell Protection and Proliferation: Research suggests that GLP-1 may have protective effects on pancreatic beta cells and can promote their proliferation and differentiation, although these effects are more pronounced in preclinical studies.

* Cardiovascular Effects: Emerging evidence points towards potential beneficial cardiovascular effects of GLP-1 signaling, including improvements in blood pressure and endothelial function.

The GLP-1 Receptor and Signaling

The actions of human glucagon-like peptide-1 are mediated through its binding to the Glucagon-like peptide-1 receptor (GLP-1R). This receptor is a G protein-coupled receptor expressed in various tissues, including the pancreas, brain, heart, and kidneys. Upon ligand binding, the GLP-1 receptor activates a signaling cascade that typically leads to the activation of adenylyl cyclase and increased intracellular cyclic adenosine monophosphate (cAMP) levels.Bioactivity of a modified human Glucagon-like peptide-1 The second extracellular loop of the Human Glucagon-like Peptide-1 Receptor has been identified as critical for receptor activation.

Therapeutic Applications and Future Directions

The potent glucose-lowering effects and other beneficial properties of GLP-1 have led to the development of GLP-1 agonists (also known as GLP-1 receptor agonists or GLP medications) as a major class of medications for the treatment of type 2 diabetes and, more recently, obesity.Is Semaglutide GLP-1 the Same as Ozempic? These peptide agonists mimic the action of endogenous GLP-1 but are engineered to be more resistant to DPP-4 degradation, resulting in a longer duration of action. Examples include medications like Ozempic (semaglutide), which is a GLP-1 agonist.Description.Glucagon Like Peptide-1is a single, glycosylated, polypeptide chain containing 30 amino acids and having a molecular mass of 3297.7 Dalton.The GLP ...

While peptide-based GLP-1 agonists have revolutionized diabetes therapy, their use has been limited by the need for subcutaneous injections. This has spurred research into developing small-molecule oral agonists of the human glucagon-like peptide-1 receptor, offering a more convenient administration route.

Research continues to explore other potential applications of GLP-1 and its analogs, including their role in neurological disorders and inflammatory conditions. The intricate physiology of glucagon-like peptide-1 continues to be a vibrant area of scientific inquiry, promising further advancements in metabolic and broader health management.

In summary, human glucagon-like peptide-1 is a vital hormone with profound effects on glucose homeostasis, appetite, and potentially cardiovascular healthHuman Glucagon-like Peptide 1 / GLP-1 (aa 7-36). Its interaction with the GLP-1 receptor forms the basis of effective therapeutic strategies for metabolic diseases, with ongoing innovation promising even more accessible and effective treatments in the future.